Veterinary Artificial Insemination Global Market Report 2024

The global veterinary artificial insemination market has grown strongly in recent years. It will grow from $4.03 billion in 2023 to $4.32 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historical period can be credited to several factors including genetic improvement programs, heightened productivity and efficiency, advancements in animal health and disease control measures, cost-effectiveness, and improved access to superior genetics.

The global veterinary artificial insemination market is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. Anticipated growth in the forecast period is expected to stem from various factors such as increased emphasis on education and training, genetic enhancement initiatives, improvements in health and disease control, the promotion of sustainable agriculture, and heightened awareness of environmental concerns, alongside a global surge in demand for animal protein. Major trends expected in this period encompass precision breeding techniques, a concentrated effort on enhancing livestock productivity and efficiency, proactive health management strategies, the adoption of sustainable agricultural practices, and expansions into new markets and species.

The growth of the veterinary artificial insemination market is anticipated to be propelled by the increasing demand for animal protein. Animal protein, derived from animals, is considered a complete protein source supplying the body with all essential amino acids. The heightened demand for animal protein has led to an increased adoption of veterinary artificial insemination to efficiently produce more animals in a shorter duration. According to an article published by The Culinary Institute of America in February 2021, the average adult male American consumes 75% more protein than required, while the average adult female American consumes 50%, primarily from animal-based sources such as meat, fish, poultry, eggs, and dairy. This robust demand for animal protein is a key driver behind the growth of the veterinary artificial insemination market.

The growing demand for livestock is another factor expected to drive the expansion of the veterinary artificial insemination market. Livestock, comprising domesticated animals raised for various agricultural purposes, such as meat, milk, eggs, wool, and leather, are pivotal in meeting the global demand for animal-derived products. Veterinary artificial insemination (AI) is a widely employed technique in livestock production to enhance breeding by introducing semen into the female reproductive tract without natural mating. This approach not only improves the quality of livestock but also enhances productivity. According to the United States Department of Agriculture, in October 2023, the European Union (EU) is projected to account for 15% of global pork, beef, and chicken meat exports by 2024. Additionally, global beef and veal production increased from 58,361 in 2021 to 59,285 in 2022. The escalating demand for livestock contributes significantly to the growth of the veterinary artificial insemination market.

Major companies and governments operating in the veterinary artificial insemination market are actively focusing on the development of innovative products, particularly livestock care services, to deliver reliable services to customers. Livestock care services encompass a diverse range of professional practices aimed at promoting the health, well-being, and productivity of farm animals. These services play a crucial role in maintaining sustainable and profitable livestock production, ensuring the safety of animal products, and safeguarding public health. As an illustration, in April 2023, the Government of Himachal Pradesh launched Project Sanjeevani, a initiative designed to provide doorstep veterinary services, particularly in remote areas. Leveraging teleconsultation and mobile applications, the project aims to connect veterinary professionals with farmers in remote areas, providing real-time advice and facilitating timely interventions, including artificial insemination, to address the challenges faced by livestock owners in accessing veterinary care.

Prominent companies in the veterinary artificial insemination market are strategically developing innovative products to gain a competitive advantage, with a specific focus on fertile sexed semen. Fertile sexed semen contains sperm capable of fertilizing an egg, holding the potential for successful pregnancy. It is a crucial component in artificial insemination (AI), a procedure involving the insertion of sperm into the uterus to achieve pregnancy. In September 2022, Cogent Breeding Ltd., a UK-based provider of sexed semen technology and modern dairy farming tools, introduced Ultraplus, the next generation of gender-sorted semen. Ultraplus stands out as the highest fertility gender-sorted semen ever available, showcasing a significant improvement in conception rates. It is now a part of 90% of Cogent's dairy offering, and a growing number of beef sires are also available in Ultraplus male sexed. The Ultraplus range offers an impressive 96-97% gender accuracy, catering to the specific needs of dairy and beef cattle breeders.

Major companies in the veterinary artificial insemination sector are also directing their efforts towards establishing specialized laboratories to better meet market demands. A specialized laboratory is equipped and staffed specifically for conducting particular types of scientific research, testing, or analysis. For instance, in September 2021, LIC, a New Zealand-based agritech cooperative company, inaugurated a new sexed semen lab. This facility played a pivotal role in facilitating the artificial insemination of approximately 4.5 million cattle during the spring mating season. The lab's primary focus was on producing high-quality sexed semen to address the increasing demand among dairy farmers. The establishment of specialized laboratories underscores the commitment of major companies to advance the capabilities and offerings in the veterinary artificial insemination market.

Major companies operating in the veterinary artificial insemination market report are Swine Genetics International, Semex, Gènes Diffusion, CRV Holding B.V., Select Sires Inc., Shipley Swine Genetics, STgenetics, Hamilton Thorne Inc., Microptic, Medical Electronic Systems LLC., Magapor S.L., CooperSurgical Inc., Proiser, Zoetis India Limited, GenePro Inc., IMV Technologies, Neogen Corporation, Bovine Elite LLC., Agtech Inc., Sires SEMEX, Genex Cooperative Inc., Alta Genetics Inc., ABS Global Inc., Cogent Breeding Ltd., Viking Genetics, Inseme S.r.l., Semen Cardona S.L., Genus plc, Trans Ova Genetics, Cattle Genetics Ltd., Cattle Breeding Services

North America was the largest region in the veterinary artificial insemination market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary artificial insemination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary artificial insemination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products within veterinary artificial insemination include normal semen and sexed semen. Normal semen is utilized for artificial insemination to improve the genetics and reproduction of farm animals. On average, a typical ejaculation yields 1.5 to 5.0 milliliters of semen, containing sperm ranging from 15 million to over 200 million per milliliter. This technique is applied in cattle, swine, ovine and caprine, equine, and other species, employing methods such as intracervical insemination, intrauterine insemination, intrauterine tub peritoneal insemination, and intratubal insemination. Veterinary hospitals, veterinary clinics, and related facilities typically carry out these procedures.

This report provides veterinary artificial insemination market statistics, including veterinary artificial insemination industry global market size, regional shares, competitors with a veterinary artificial insemination market share, detailed veterinary artificial insemination market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary artificial insemination industry. This veterinary artificial insemination market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary artificial insemination market consists of revenues earned by entities by providing veterinary artificial insemination services such breeding, scientific doorstep AI facilities, crossbreeding, selective breeding, pure breeding. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary artificial insemination market also includes sales of AI kit, AI gun, AI sheaths, clinical thermometer which are used in providing veterinary artificial insemination services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.